Trametinib

Overview

Trametinib is a kinase inhibitor used for the treatment of melanoma, specifically targeting MEK1 and MEK2. It is often used in combination with other medications to treat unresectable or metastatic melanoma with a mutation in the BRAF gene.

API suppliers (1)

Suppliers of Trametinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia1 active DMF

Therapeutic areas